BB Biotech AG (BBZA.DE) is in Healthcare, Biotechnology, based in Switzerland, listed on XETRA. Market cap 2.85B EUR. 52-week range 33.40 to 52.00 EUR. Data as of 2026-10-09.
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.